Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results

Autor: Fleischer, David M., Shreffler, Wayne G., Campbell, Dianne E., Green, Todd D., Anvari, Sara, Assa’ad, Amal, Bégin, Philippe, Beyer, Kirsten, Bird, J. Andrew, Brown-Whitehorn, Terri, Byrne, Aideen, Chan, Edmond S., Cheema, Amarjit, Chinthrajah, Sharon, Chong, Hey Jin, Davis, Carla M., Ford, Lara S., Gagnon, Rémi, Greenhawt, Matthew, Hourihane, Jonathan O’B., Jones, Stacie M., Kim, Edwin H., Lange, Lars, Lanser, Bruce J., Leonard, Stephanie, Mahler, Vera, Maronna, Andreas, Nowak-Wegrzyn, Anna, Oriel, Roxanne C., O’Sullivan, Michael, Petroni, Daniel, Pongracic, Jacqueline A., Prescott, Susan L., Schneider, Lynda C., Smith, Peter, Staab, Doris, Sussman, Gordon, Wood, Robert, Yang, William H., Lambert, Romain, Peillon, Aurélie, Bois, Timothée, Sampson, Hugh A.
Zdroj: In The Journal of Allergy and Clinical Immunology October 2020 146(4):863-874
Databáze: ScienceDirect
Externí odkaz: